Feasibility, acceptability and appropriateness of a reproductive patient reported outcome measure for cancer survivors

Autor: Chantelle D’Souza, Rebecca Deans, Brigitte Gerstl, Christina Signorelli, Kristen A Neville, Claire E. Wakefield, Richard J. Cohn, Antoinette Anazodo, Karen Johnston, Tejnei Vaishnav
Rok vydání: 2021
Předmět:
Questionnaires
Male
Cancer Treatment
Pilot Projects
Ambulatory Care Facilities
Cancer Survivors
Neoplasms
Surveys and Questionnaires
Breast Tumors
Testicular Cancer
Medicine and Health Sciences
Genitourinary Cancers
Reproductive health
Multidisciplinary
Reproduction
Middle Aged
female genital diseases and pregnancy complications
Reproductive Health
Oncology
Research Design
Medicine
Female
Patient-reported outcome
Research Article
Adult
medicine.medical_specialty
Adolescent
Science
Urology
Sexual Behavior
MEDLINE
Audit
Research and Analysis Methods
Young Adult
Quality of life (healthcare)
Breast cancer
Diagnostic Medicine
Survivorship curve
Breast Cancer
Mental Health and Psychiatry
Cancer Detection and Diagnosis
medicine
Humans
Oncofertility
Survey Research
business.industry
Cancers and Neoplasms
medicine.disease
Genitourinary Tract Tumors
Family medicine
Feasibility Studies
business
Zdroj: PLoS ONE
PLoS ONE, Vol 16, Iss 8, p e0256497 (2021)
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0256497
Popis: Background Cancer patients can experience a number of reproductive complications as a result of cancer treatment and may benefit from reproductive preventative health strategies. A Reproductive Survivorship Patient Reported Outcome Measure (RS-PROM) is not currently available but could assist patients address reproductive concerns. Purpose To develop and test the acceptability, feasibility and appropriateness of a RS-PROM tool to be used to assess reproductive needs of cancer survivors aged 18–45 years. Methods We reviewed the outcomes of a recently published audit of reproductive care provided in our cancer survivorship clinic to identify gaps in current service provided and used this along with available validated reproductive measures, to develop this pilot RS-PROM. Survivors aged 18–45 years either attending the SCH survivorship clinic over a 1-year period or participants on the Australasian Oncofertility Registry (AOFR) who had agreed to be contacted for future research studies were asked to complete the RS-PROM and a questionnaire on the acceptability, feasibility and appropriateness of content included. Results One-hundred and fifty patients participated (61.3% females). Median age at cancer diagnosis was 24.5 years (range: 2–45 years). Eighty percent of participants reported the length of the RS-PROM was “just right”, 92% agreed they would not mind completing the RS-PROM and 92.7% were willing to answer all questions, with 97% agreeing that the RS-PROM would be an important tool in addressing difficult sexual/reproductive topics concerning with healthcare professionals. Conclusion The large majority of survivors participating in our pilot study found the RS-PROM to be an acceptable, feasible and useful tool to assist discussions of their sexual and reproductive health concerns and experiences with their clinical team.
Databáze: OpenAIRE
Externí odkaz: